Hartford Investment Management Co. Has $1.28 Million Position in DENTSPLY SIRONA Inc (XRAY)

Hartford Investment Management Co. cut its position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 33.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,191 shares of the medical instruments supplier’s stock after selling 14,738 shares during the quarter. Hartford Investment Management Co.’s holdings in DENTSPLY SIRONA were worth $1,278,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. IBM Retirement Fund raised its stake in DENTSPLY SIRONA by 49.1% in the 1st quarter. IBM Retirement Fund now owns 4,955 shares of the medical instruments supplier’s stock valued at $249,000 after purchasing an additional 1,631 shares during the last quarter. NuWave Investment Management LLC increased its stake in shares of DENTSPLY SIRONA by 184.6% in the 1st quarter. NuWave Investment Management LLC now owns 5,237 shares of the medical instruments supplier’s stock worth $263,000 after acquiring an additional 3,397 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $313,000. Riverhead Capital Management LLC grew its holdings in shares of DENTSPLY SIRONA by 17.4% during the 1st quarter. Riverhead Capital Management LLC now owns 7,661 shares of the medical instruments supplier’s stock worth $385,000 after purchasing an additional 1,136 shares during the period. Finally, Koch Industries Inc. purchased a new position in shares of DENTSPLY SIRONA during the 1st quarter worth $385,000. Institutional investors and hedge funds own 94.10% of the company’s stock.

In related news, Director Michael J. Coleman sold 6,038 shares of the stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $43.97, for a total value of $265,490.86. Following the completion of the transaction, the director now owns 26,960 shares of the company’s stock, valued at $1,185,431.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michael C. Alfano sold 1,404 shares of the stock in a transaction dated Wednesday, May 30th. The shares were sold at an average price of $45.83, for a total value of $64,345.32. Following the completion of the transaction, the director now directly owns 13,458 shares of the company’s stock, valued at approximately $616,780.14. The disclosure for this sale can be found here. Corporate insiders own 1.93% of the company’s stock.

A number of equities analysts have recently weighed in on the company. Barrington Research cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday. Barclays lowered their target price on DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating for the company in a report on Wednesday. Jefferies Financial Group decreased their price objective on DENTSPLY SIRONA from $58.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday. Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $57.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, HC Wainwright reissued a “hold” rating and set a $40.00 target price on shares of DENTSPLY SIRONA in a research report on Wednesday. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $52.18.

DENTSPLY SIRONA opened at $39.02 on Friday, Marketbeat Ratings reports. The company has a current ratio of 1.69, a quick ratio of 1.46 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $8.98 billion, a P/E ratio of 14.67, a price-to-earnings-growth ratio of 2.32 and a beta of 1.27. DENTSPLY SIRONA Inc has a 1-year low of $38.80 and a 1-year high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.01. The company had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.03 billion. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. During the same period in the previous year, the firm posted $0.65 earnings per share. equities analysts anticipate that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 12th. Investors of record on Friday, September 28th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.35 annualized dividend and a yield of 0.90%. DENTSPLY SIRONA’s payout ratio is currently 13.16%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: How to Invest in Marijuana Stocks

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply